NCT02915341

Brief Summary

The overall objective of this study is to extend previous work in the development of methods to automatically detect the timing of cocaine use from cardiac interbeat interval and physical activity data derived from wearable, unobtrusive mobile sensor technologies. The specific objectives of this protocol are to characterize under which conditions high quality continuous interbeat interval data and physical activity data can be obtained from a specially developed smartwatch device in the natural field setting among a population of cocaine users. In addition to identifying common failure scenarios and understanding wearability/usage patterns when collecting interbeat interval from smartwatches, this study will extend previous work in the detection of cocaine use via interbeat interval and physical activity data that were previously obtained from wearable chestband sensors. Information from this study will contribute toward the adaptation of the investigators' existing computational model for detecting cocaine use via the chest sensors, so it can be applied to the interbeat and physical activity data obtained from less obtrusive smartwatches.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2016

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 20, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 27, 2016

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 24, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 24, 2018

Completed
Last Updated

July 18, 2018

Status Verified

June 1, 2018

Enrollment Period

2 years

First QC Date

September 20, 2016

Last Update Submit

July 15, 2018

Conditions

Outcome Measures

Primary Outcomes (3)

  • Ambulatory physiological and activity data

    Data yield of ambulatory physiological and activity data will be used to characterize the feasibility of using smartwatches to collect reliable interbeat interval and physical activity data in the natural field setting, sensor usage patterns (e.g., hours per day of device wear, periods of device removal), and common failure scenarios (e.g., poor sensor data quality, missing data due to removal of the device, or other factors which may affect data yield). Ambulatory physiological and activity data will be collected using passive mobile sensor data collection platforms (AutoSense chest sensors and smartwatches). This data is collected via AutoSense sensors and will utilize participants' heart beats, which will be continually streamed into the database at the Mobile Sensor Data-to-Knowledge Center of Excellence (University of Memphis). This is one assessment with one unit of measurement (heart rate) that will inform the multiple aspects of this outcome.

    14 days

  • Device wearability

    Device wearability (e.g., acceptability and burden) will be characterized via user questionnaires.

    14 days

  • Cocaine use

    Real-time self-report of cocaine use via Ecological Momentary Assessment (EMA) questionnaire prompts via the smartphone device, retrospective recall of drug use via Timeline Followback (TLFB), and urine drug assay for cocaine and other drugs of abuse will be used to adapt the computational model, so that it can be applied to the interbeat and physical activity data obtained from smartwatches. These measurements of cocaine use will be aggregated to arrive at one reported value (cocaine use episodes) to inform the model.

    14 days

Secondary Outcomes (2)

  • Device comparison

    Through study completion, an average of 18 months

  • Cocaine detection specificity

    Through study completion, an average of 18 months

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The proposed study will be conducted with 25 cocaine users from the parent clinical trial who agree to wear the AutoSense smartwatches and chestband for two weeks. Participants in the parent clinical trial are unemployed, cocaine-using adults who inject drugs and are enrolled in opioid agonist treatment. There are no study groups or randomization.

You may qualify if:

  • Be enrolled in the parent clinical trial for at least one week.
  • Be active in the Induction Period (days 8-35) of the parent clinical trial at the time of study intake.
  • Provide a cocaine-positive urine sample in the week prior (based on thrice-weekly urine samples collected as a part of the parent trial).
  • Be available for the duration of the study (16 days total) and able to attend weekday research check-in sessions at the recruitment site.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center for Learning and Health, Johns Hopkins University

Baltimore, Maryland, 21205, United States

Location

Related Publications (3)

  • Hossain SM, Ali AA, Rahman M, Ertin E, Epstein D, Kennedy A, Preston K, Umbricht A, Chen Y, Kumar S. Identifying Drug (Cocaine) Intake Events from Acute Physiological Response in the Presence of Free-living Physical Activity. IPSN. 2014;2014:71-82.

    PMID: 25531010BACKGROUND
  • Ertin, E., Stohs, N., Kumar, S., Raij, A.B., al'Absi, M., Kwon, T., Mitra, S., Shah, S., & Jeong, J.W. (2011). AutoSense: Unobtrusively wearable sensor suite for inferencing of onset, causality, and consequences of stress in the field: Proceedings of the 9th ACM Conference on Embedded Networked Sensor Systems (SenSys) (pp. 274-287). New York, NY: Association for Computing Machinery.

    BACKGROUND
  • Ertin E, Sugavanam N, Holtyn AF, Preston KL, Bertz JW, Marsch LA, McLeman B, Shmueli-Blumberg D, Collins J, King JS, McCormack J, Ghitza UE. An Examination of the Feasibility of Detecting Cocaine Use Using Smartwatches. Front Psychiatry. 2021 Jun 24;12:674691. doi: 10.3389/fpsyt.2021.674691. eCollection 2021.

MeSH Terms

Conditions

Cocaine-Related Disorders

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental Disorders

Study Officials

  • Lisa A. Marsch, PhD

    Dartmouth College

    PRINCIPAL INVESTIGATOR
  • Santosh Kumar, PhD

    University of Memphis

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 20, 2016

First Posted

September 27, 2016

Study Start

May 1, 2016

Primary Completion

April 24, 2018

Study Completion

April 24, 2018

Last Updated

July 18, 2018

Record last verified: 2018-06

Data Sharing

IPD Sharing
Will share

De-identified data will be reviewed by IRB and shared with DSMB every 6 months, as per the monitoring protocol set forth by the CTN and this study.

Locations